Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 5:51 PM UTC
| NCT Number | NCT06881784 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 590 participants |
| Active Locations | 45 sites in the US |
| Sponsor | Revolution Medicines, Inc. |
| Last Updated on CT.gov | September 29, 2026 (2 weeks ago) |
As of October 15, 2026: Clinical trial NCT06881784 is currently recruiting participants. This phase3 study for lung cancer is actively seeking new participants at 45 locations across the United States. The study is sponsored by Revolution Medicines, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06881784 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 45 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06881784 was last updated 2 weeks ago (September 29, 2026). HelloStudys verifies this status automatically.